ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR EpitopeAndrew C. Phillips, Edward B. Reilly, Laura M. McKay et al.|Molecular Cancer Therapeutics|2016Cited by 185
Data from ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR EpitopeAndrew C. Phillips, Edward B. Reilly, Erwin R. Boghaert et al.|Unknown|2023Cited by 0
Supplementary Table 1, Table 2; Supplementary Figure 1 from ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR EpitopeAndrew C. Phillips, Edward B. Reilly, Erwin R. Boghaert et al.|Unknown|2023Cited by 0
Supplementary Table 1, Table 2; Supplementary Figure 1 from ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR EpitopeAndrew C. Phillips, Edward B. Reilly, Erwin R. Boghaert et al.|Unknown|2023Cited by 0
Data from ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR EpitopeAndrew C. Phillips, Edward B. Reilly, Erwin R. Boghaert et al.|Unknown|2023Cited by 0